The company, launched with help from ex-Novartis executives, is targeting glutamate signaling in the brain to help treat ...

Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...

The Series B round will help the Aditum Bio-backed startup fund two mid-stage clinical trials in people with alcohol and cocaine use disorders.

BEIJING, March 24 (Xinhua) -- Chinese Vice President Han Zheng met with Swire Pacific Limited chairman Merlin Swire, and Novartis CEO Vas Narasimhan on Monday in Beijing, who are here for the China ...

Research in mice identifies protein responsible for regulating gut movement in response to pressure, exercise, and ...

Augustine Therapeutics has raised €78m ($85m) in funding to support the development of its lead candidate as it enters a ...

After every meal, the intestines perform an action called peristalsis — moving food through their hollow interiors with coordinated contractions and ...

Switzerland has so far been spared tariff threats from the new US President Donald Trump. Nevertheless, Swiss companies are taking precautions.

The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.

SINGAPORE – A new programme has launched in Singapore to formally study the applications of ribonucleic acid (RNA) in vaccine ...

More and more people are talking about Novartis over the last few weeks. Is it worth buying the Pharmaceutical stock at a price of $112.13? Only time will tell. The information below will give you a ...

The medical sector is one of the major adopters of artificial intelligence (AI), which is currently being used to synthesize ...